Advertisement

Molecular and Cellular Biochemistry

, Volume 375, Issue 1–2, pp 179–183 | Cite as

Polymorphism of catechol-o-methyltransferase and uterine leiomyoma

  • Omer AtesEmail author
  • Fazli Demirturk
  • Muhammet Toprak
  • Saime Sezer
Article
  • 305 Downloads

Abstract

Uterine leiomyoma (ULM) is the most common gynecological benign tumor that is affecting around 20–50 % of women over the age of 30. Although its molecular pathogenesis is still unknown, ULM has a multifactorial etiology determined by both genetics and environmental factors. The present study was designed to find out whether Val158Met polymorphism in the catechol-o-methyltransferase (COMT) gene is associated with the risk of ULM. We analyzed COMT Val158Met polymorphism in 105 ULMs patients and 105 healthy subjects using a polymerase chain reaction-based restriction fragment length polymorphism assay. We found remarkably similar frequencies in ULM compared with controls for COMT Val158Met genotypes and alleles, and no association was found between ULM and this polymorphism (p = 0.46). The COMT 158 Met allele in patients with large (≥5 cm) fibroids was higher than in patients with small (<5 cm) fibroids, and significant association was found between fibroid size and COMT 158 Met allele (p = 0.011, OR 0.50, 95 %CI 0.28–0.90). Our results reflect that COMT Val158Met polymorphism is not associated with an increased risk of ULMs, but Val158Met polymorphism may be a risk factor for development of large fibroids in Turkish patients with ULM.

Keywords

COMT Uterine leiomyoma Genetic susceptibility Polymorphism 

Notes

Acknowledgments

This work was supported by the Gaziosmanpasa University Scientific Research Projects Fund, Project numbers 2011/93.

Conflict of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

References

  1. 1.
    Miura S, Khan KN, Kitajima M et al (2006) Differential infiltration of macrophages and prostaglandin production by different uterine leiomyomas. Hum Reprod 21:2545–2554PubMedCrossRefGoogle Scholar
  2. 2.
    Cramer SF, Patel A (1990) The frequency of uterine leiomyomas. Am J Clin Pathol 94:435–438PubMedGoogle Scholar
  3. 3.
    Luoto R, Kaprio J, Rutanen EM, Taipale P, Perola M, Koskenvuo M (2000) Heritability and risk factors of uterine fibroids—the Finnish Twin Cohort study. Maturitas 37:15–26PubMedCrossRefGoogle Scholar
  4. 4.
    Shaik NA, Lone WG, Khan IA, Rao KP, Kodati VL, Hasan Q (2011) Enhanced transcription of estrogen receptor α and mitochondrial cytochrome b genes in uterine leiomyomas. Gynecol Endocrinol 27:1094–1098PubMedCrossRefGoogle Scholar
  5. 5.
    Barão MA, Oliveira E, Gomes MT, da Silva ID, Sartori MG, Girão MJ, Castro Rde A (2010) The role of MSP I CYP1A1 gene polymorphism in the development of uterine fibroids. Fertil Steril 94:2783–2785PubMedCrossRefGoogle Scholar
  6. 6.
    Ivanova TI, Kondrashova TV, Krikunova LI, Smirnova IA, Shentereva NI, Sychenkova NI, Rykova EV, Zharikova IA, Khorokhorina VA, Riabchenko NI, Zamulaeva IA (2010) The polymorphism of catechol-o-methyltransferase (COMT) and hemochromatosis (HFE) genes in the radiocontaminated regions residents with different chromosome aberration frequency. Radiats Biol Radioecol 50:117–127PubMedGoogle Scholar
  7. 7.
    Teng XY, Liu GQ, Diao XL, Wu ZY, Li L, Zhang W, Zhang X, Su Q (2010) CAG repeats in the androgen receptor gene are shorter in patients with pulmonary, esophageal or bladder carcinoma and longer in women with uterine leiomyoma. Oncol Rep 23:811–818PubMedGoogle Scholar
  8. 8.
    Pietrowski D, Thewes R, Sator M, Denschlag D, Keck C, Tempfer C (2009) Uterine leiomyoma is associated with a polymorphism in the interleukin 1-beta gene. Am J Reprod Immunol 62:112–117PubMedCrossRefGoogle Scholar
  9. 9.
    de Oliveira E, de Aquino CR, Vieira Gomes MT, da Cotrim Guerreiro SID, Baracat EC, de Lima GR, Ferreira Sartori MG, Batista Castello Girão MJ (2009) Role of glutathione S-transferase (GSTM1) gene polymorphism in development of uterine fibroids. Fertil Steril 91:1496–1498PubMedCrossRefGoogle Scholar
  10. 10.
    Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH (2008) T allele for VEGF-460 gene polymorphism at 5′-untranslated region is associated with higher susceptibility of leiomyoma. Biochem Genet 46:356–361PubMedCrossRefGoogle Scholar
  11. 11.
    Zhu BT, Conney AH (1998) Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1–27PubMedCrossRefGoogle Scholar
  12. 12.
    Lachman HM, Papolos DF, Saito T et al (1996) Human catechol-o-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243–250PubMedCrossRefGoogle Scholar
  13. 13.
    Morikawa J, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Kitao K, Deguchi M, Ohara N, Maruo T (2008) Association study between catechol-o-methyltransferase polymorphisms and uterine leiomyomas in a Japanese population. Clin Exp Obstet Gynecol 35:35–40PubMedGoogle Scholar
  14. 14.
    Denschlag D, Bentz EK, Hefler L, Pietrowski D, Zeillinger R, Tempfer C, Tong D (2006) Genotype distribution of estrogen receptor-alpha, catechol-o-methyltransferase, and cytochrome P450 17 gene polymorphisms in Caucasian women with uterine leiomyomas. Fertil Steril 85:462–467PubMedCrossRefGoogle Scholar
  15. 15.
    Al-Hendy A, Salama SA (2006) Catechol-o-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 13:136–144PubMedCrossRefGoogle Scholar
  16. 16.
    Gooden KM, Schroeder JC, North KE, Gammon MD, Hartmann KE, Taylor J, Baird DD (2007) Val153Met polymorphism of catechol-o-methyltransferase and prevalence of uterine leiomyomata. Reprod Sci 14:117–120PubMedCrossRefGoogle Scholar
  17. 17.
    Lavigne JA, Helzlsouer KJ, Huang HY et al (1997) An association between the allele coding for a low activity variant of catechol-o-methyltransferase and risk of breast cancer. Cancer Res 57:5493–5497PubMedGoogle Scholar
  18. 18.
    Baird DD, Dunson DB, Hill MC et al (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 1881:100–107CrossRefGoogle Scholar
  19. 19.
    Myers E, Barber M, Couchman G et al (2001) Management of uterine fibroids. AHRQ Publication No. 01-E052. In: Vol. 1, AHRQ Evidence Reports, No. 24Google Scholar
  20. 20.
    Kjerulff KH, Langenberg P, Seidman JD et al (1996) Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 41:483–490PubMedGoogle Scholar
  21. 21.
    Othman EE, Al-Hendy A (2008) Molecular genetics and racial disparities of uterine leiomyomas. Best Pract Res Clin Obstet Gynaecol 22:589–601PubMedCrossRefGoogle Scholar
  22. 22.
    de Oliveira E, de Aquino CR, Gomes MT, da Silva ID, Baracat EC, de Lima GR, Sartori MG, Girão MJ (2008) The catechol-o-methyltransferase (COMT) gene polymorphism and prevalence of uterine fibroids. Maturitas 60:235–238PubMedCrossRefGoogle Scholar
  23. 23.
    Huang CS, Chern HD, Chang KJ, cheng CW, Hsu SM, Shen CY (1999) Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 59:4870–4875PubMedGoogle Scholar
  24. 24.
    Zhao XM, Xie MQ, Yang DZ et al (2007) Polymorphism of catechol-o-methyltransferase gene in relation to the risk of endometrial cancer. Zhonghua Fu Chan Ke Za Zhi 42:116–119PubMedGoogle Scholar
  25. 25.
    Juo SH, Wang TN, Lee JN, Wu MT, Long CY, Tsai EM (2006) CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women. Hum Reprod 21:1498–1502PubMedCrossRefGoogle Scholar
  26. 26.
    Zhu BT, Conney AH (1998) Functional role estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19:1–27PubMedCrossRefGoogle Scholar
  27. 27.
    Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT (1995) 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 92:9220–9224PubMedCrossRefGoogle Scholar
  28. 28.
    Ye Y, Cheng X, Luo HB, Liu L, Li YB, Hou YP (2008) CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Genet 25:389–394PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Omer Ates
    • 1
    Email author
  • Fazli Demirturk
    • 2
  • Muhammet Toprak
    • 2
  • Saime Sezer
    • 1
  1. 1.Department of Medical BiologyFaculty of Medicine, Gaziosmanpasa UniversityTokatTurkey
  2. 2.Department of Obstetrics and GynecologyFaculty of Medicine, Gaziosmanpasa UniversityTokatTurkey

Personalised recommendations